Non-Hodgkin Lymphoma (NHL) Market Size, Share, Trends, Demand, Growth and Competitive Analysis| MarkNtel
Non-Hodgkin Lymphoma (NHL) Market Overview:
2022-28
Base Year: 2021
Historical Years: 2017-20
Forecast Years: 2022-27
The Non-Hodgkin Lymphoma (NHL) Market is expected to grow at around 7.6%
CAGR during the forecast period, i.e., 2022-27. The growth of the market would
be driven primarily by the rising prevalence of B-cell lymphoma worldwide and
mounting side effects of chemotherapy treatment, which, in turn, is leading to
substantial R&D investments in procuring novel drugs to cure NHL. Besides,
rapid drug approvals for B-cell lymphoma treatment in both developed &
emerging countries and the impressive pipeline of targeted therapies, coupled
with the label expansion of currently available therapies for treating various
subtypes of NHL, are also driving the market.
Markntel Advisor’s
Non-Hodgkin Lymphoma (NHL) Market
Insights report provides the current and forecast market analysis, individual
leading companies' market shares, challenges, Non-Hodgkin Lymphoma (NHL) Market
drivers, barriers, Non-Hodgkin Lymphoma (NHL) Market Trends, and Key Players in
Non-Hodgkin Lymphoma (NHL) Market.
Download a sample copy of the Report:
https://www.marknteladvisors.com/query/request-sample/non-hodgkins-lymphoma-nhl-treatment-market.html
✅In
case you missed it, we are currently revising our reports. Click on the below
to get the latest research data with forecast for years 2025 to 2030, including
market size, industry trends, and competitive analysis. It wouldn’t take long
for the team to deliver the most recent version of the report.
Non-Hodgkin Lymphoma (NHL) Market Dynamics:
2022-27
Mounting Incidence
of B-Cell Lymphoma & Improved Prognosis using Advanced Therapeutics: The
growing patient pool for blood cancers, especially B-cell lymphomas, i.e.,
instigating the need for better clinical & therapeutic patient outcomes in
refractory or relapsed cases, is the prime aspect projected to drive the Global
Non-Hodgkin Lymphoma (NHL) Market during 2022-27. Moreover, rigorous R&D
activities in developing efficient therapeutics for Non-Hodgkin Lymphoma have
led to an overall improved prognosis. It, in turn, is driving more individuals
toward adopting advanced treatments, which further projects remunerative
prospects for the global market over the forecast years.
Browse Full Report with Detail Analysis -
https://www.marknteladvisors.com/research-library/non-hodgkins-lymphoma-nhl-treatment-market.html
Non-Hodgkin Lymphoma (NHL) Market (2022-27):
Segmentation Outlook
The market report
has segmented the market into the following categories:
·
By Diagnosis
o Biopsy
§ Excisional or Incisional
§ Needle
§ Bone Marrow Aspiration & Biopsy
§ Lumbar Puncture (Spinal Tap)
o Lab Tests
o Imaging
§ Chest X-Ray
§ CT Scan
§ MRI
§ PET Scan
§ Ultrasound
o Blood Tests
·
By Treatment
o Surgery
o Stem Cell Transplant
o Chemotherapy
o Immunotherapy
§ Monoclonal Antibodies
§ Antibody-drug Conjugates
§ Immunomodulatory Drugs
§ CAR T-cell therapy
o Targeted Therapy
o Radiation Therapy
According to
report, Among all treatments, monoclonal antibodies (mAbs) of immunotherapy accounted
for the largest share in the Global Non-Hodgkin Lymphoma (NHL) Market owing to
their outstanding mechanism of action.
·
By End-User
o Hospitals
o Specialty Clinics
o Others (Ambulatory Surgery Centers, etc.)
·
By Region
o North America
o South America
o Europe
o Middle East & Africa
o Asia-Pacific
Note - If there are any particular details
you need that are not currently included in the report, we will be happy to
provide them as part of our customization
services.
Top Companies Operating in the Non-Hodgkin
Lymphoma (NHL) Market:
- AstraZeneca PLC
- AbbVie Inc.
- Baxter International Inc.
- Bayer AG
- Bristol Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline PLC
- F. Hoffmann-La Roche AG
- Merck & Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Others
Reports Delivery Format - Market research
studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint
formats. Within 24 hours of the payment being successfully received, the report
will be sent to your email address
About Us –
We are a leading
market research company, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.
Our specialization
in niche industries & emerging geographies allows our clients to formulate
their strategies in a much more informed way and entail parameters like
Go-to-Market (GTM), product development, feasibility analysis, project scoping,
market segmentation, competitive benchmarking, market sizing & forecasting,
& trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564
Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate
Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Comments
Post a Comment